Biopsy Devises Market, 2012 to 2023
Biopsy Devices Market
Increase in the prevalence of various cancer diseases such as prostate, breast, and lung cancers, technological development of the biopsy devices, increase the adoption of integrated biopsy technologies, and lack of screening tests for the specific type of cancer are anticipated to drive the biopsy devices market over the forecast period. In addition, increase the awareness about the chronic diseases, rise in global geriatric population, increase in the preference for minimally invasive procedures, and growing importance of disease screening for early treatment expected to propel the biopsy devices market. However, a high cost of the biopsy devices, unfavourable reimbursement policies, stringent regulatory guidelines, and lack of skilled technicians might hamper the growth of Biopsy devices market.
The biopsy is a minimally invasive surgical process performed to remove the tissue from the body for the determination of presence or extent of diseases such as cancer and inflammatory conditions. Generally, the biopsy is carried by radiologists, surgeons, and interventional cardiologists to confirm the presence of disease. A biopsy can be carried for the majority of organs in the body with the aid of specific biopsy devices. The various types of biopsy devices include skin biopsy, shave biopsy, fine needle aspiration, excision and incision biopsy, and vacuum-assisted biopsy among others. Conventional biopsy devices are complimented with the advanced imaging technologies like stereotactic-guided biopsy, CT scan, MRI-guided, ultrasound-guided biopsy, and others. These devices are helping to perform the biopsies in critical areas such as liver, kidney, and lungs.
Biopsy devises market is segmented on the basis of device type, application, imaging technologies, and end user.
Based on the device type, biopsy devices market is segmented into the following:
Core biopsy devices
Core biopsy needles
Core biopsy guns
Needle-based biopsy devices
Vacuum-assisted biopsy devices
Needles
Guns
Aspiration biopsy needles
Others
Based on the application, biopsy devices market is segmented into the following:
Gastrointestinal biopsy
Lung
Liver
Breast biopsy
Gynaecological
Kidney
Others
Based on the imaging technologies, biopsy devices market is segmented into the following:
Ultrasound-guided biopsy
Stereotactic guided biopsy
CT scan
MRI guided biopsy
Others
Based on the end user, Biopsy devices market is segmented into the following:
Hospitals
Clinics
Diagnostic Centres
Biopsy devises market is growing at a significant CAGR due to increase in the prevalence of cancer around the globe. Technological advancements of biopsy devices and increase in the demand for biopsy devices in disease screening for early treatment propel the biopsy devices market. Acquisitions and mergers, collaborations, product and patent approvals, and product launches are key strategies followed by the players for increasing market revenue growth. For instance, in September 2014, Argon Medical Devices, Inc. acquired Promex Technologies, LLC for diversification of business segment into the soft-tissue biopsy devices. Similarly, in September 2015, MDxHealth acquired the NovioGendix for developing its product portfolio in the prostate cancer diagnosis. Furthermore, in January 2015, Intact Medical Corp. has received the FDA approval for its minimally invasive breast biopsy devices.
Geographically, Biopsy devices market is segmented into Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. The growth of North America in biopsy devices market is attributed to increase in R&D activities, technological advancements of biopsy devices, increase in the prevalence of cancer disease (As per National Cancer Institute, in 2016, about 1,685, 210 new cancer cases were diagnosed in the U.S. and approximately 595,690 people will die from cancer), and availability of skilled professionals expected to fuel the biopsy devices market in the region. Europe holds a major share owing to increase in the prevalence of cancer (As per WHO Europe statistics, in 2012, more than 3.7 Mn new cases and 1.9 Mn deaths occur each year due to cancer), rise in the healthcare expenditure, increase in the R&D activities, and rise in adoption of minimally invasive procedures are anticipated to drive the biopsy devices market in Europe region. Asia Pacific region is expected to exhibit significant growth over the forecast period due to increase in the geriatric population especially in Japan, China, and India, increase in the prevalence of various types of cancers, and rise in the medical tourism in Asia Pacific region might propel the biopsy devices market.
Some of the players in Biopsy devices market are Becton, Dickinson and Company (U.S.), Argon Medical Devices (U.S.), Cardinal Health, Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Olympus Corporation (Japan), Hologic, Inc. (U.S.), SmartTarget Ltd. (U.K.), MDxHealth (Belgium), and Intact Medical Corporation (U.S.) to name a few.
In August 2017, Hologic launched Bravera a breast biopsy system used for real-time breast biopsy and verification
In September 2016, SmartTarget Ltd launched its CE marked biopsy device used in the diagnosis of prostate cancer in U.K.
Increase in the prevalence of various cancer diseases such as prostate, breast, and lung cancers, technological development of the biopsy devices, increase the adoption of integrated biopsy technologies, and lack of screening tests for the specific type of cancer are anticipated to drive the biopsy devices market over the forecast period. In addition, increase the awareness about the chronic diseases, rise in global geriatric population, increase in the preference for minimally invasive procedures, and growing importance of disease screening for early treatment expected to propel the biopsy devices market. However, a high cost of the biopsy devices, unfavourable reimbursement policies, stringent regulatory guidelines, and lack of skilled technicians might hamper the growth of Biopsy devices market.
The biopsy is a minimally invasive surgical process performed to remove the tissue from the body for the determination of presence or extent of diseases such as cancer and inflammatory conditions. Generally, the biopsy is carried by radiologists, surgeons, and interventional cardiologists to confirm the presence of disease. A biopsy can be carried for the majority of organs in the body with the aid of specific biopsy devices. The various types of biopsy devices include skin biopsy, shave biopsy, fine needle aspiration, excision and incision biopsy, and vacuum-assisted biopsy among others. Conventional biopsy devices are complimented with the advanced imaging technologies like stereotactic-guided biopsy, CT scan, MRI-guided, ultrasound-guided biopsy, and others. These devices are helping to perform the biopsies in critical areas such as liver, kidney, and lungs.
Biopsy devises market is segmented on the basis of device type, application, imaging technologies, and end user.
Based on the device type, biopsy devices market is segmented into the following:
Core biopsy devices
Core biopsy needles
Core biopsy guns
Needle-based biopsy devices
Vacuum-assisted biopsy devices
Needles
Guns
Aspiration biopsy needles
Others
Based on the application, biopsy devices market is segmented into the following:
Gastrointestinal biopsy
Lung
Liver
Breast biopsy
Gynaecological
Kidney
Others
Based on the imaging technologies, biopsy devices market is segmented into the following:
Ultrasound-guided biopsy
Stereotactic guided biopsy
CT scan
MRI guided biopsy
Others
Based on the end user, Biopsy devices market is segmented into the following:
Hospitals
Clinics
Diagnostic Centres
Biopsy devises market is growing at a significant CAGR due to increase in the prevalence of cancer around the globe. Technological advancements of biopsy devices and increase in the demand for biopsy devices in disease screening for early treatment propel the biopsy devices market. Acquisitions and mergers, collaborations, product and patent approvals, and product launches are key strategies followed by the players for increasing market revenue growth. For instance, in September 2014, Argon Medical Devices, Inc. acquired Promex Technologies, LLC for diversification of business segment into the soft-tissue biopsy devices. Similarly, in September 2015, MDxHealth acquired the NovioGendix for developing its product portfolio in the prostate cancer diagnosis. Furthermore, in January 2015, Intact Medical Corp. has received the FDA approval for its minimally invasive breast biopsy devices.
Geographically, Biopsy devices market is segmented into Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa. The growth of North America in biopsy devices market is attributed to increase in R&D activities, technological advancements of biopsy devices, increase in the prevalence of cancer disease (As per National Cancer Institute, in 2016, about 1,685, 210 new cancer cases were diagnosed in the U.S. and approximately 595,690 people will die from cancer), and availability of skilled professionals expected to fuel the biopsy devices market in the region. Europe holds a major share owing to increase in the prevalence of cancer (As per WHO Europe statistics, in 2012, more than 3.7 Mn new cases and 1.9 Mn deaths occur each year due to cancer), rise in the healthcare expenditure, increase in the R&D activities, and rise in adoption of minimally invasive procedures are anticipated to drive the biopsy devices market in Europe region. Asia Pacific region is expected to exhibit significant growth over the forecast period due to increase in the geriatric population especially in Japan, China, and India, increase in the prevalence of various types of cancers, and rise in the medical tourism in Asia Pacific region might propel the biopsy devices market.
Some of the players in Biopsy devices market are Becton, Dickinson and Company (U.S.), Argon Medical Devices (U.S.), Cardinal Health, Inc. (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Olympus Corporation (Japan), Hologic, Inc. (U.S.), SmartTarget Ltd. (U.K.), MDxHealth (Belgium), and Intact Medical Corporation (U.S.) to name a few.
In August 2017, Hologic launched Bravera a breast biopsy system used for real-time breast biopsy and verification
In September 2016, SmartTarget Ltd launched its CE marked biopsy device used in the diagnosis of prostate cancer in U.K.
1. EXECUTIVE SUMMARY
2. GLOBAL BIOPSY DEVICES MARKET INTRODUCTION
2.1. Global Biopsy Devices Market – Taxonomy
2.2. Global Biopsy Devices Market –Definitions
2.2.1. Device
2.2.2. Application
2.2.3. Imaging Technology
2.2.4. End-User
3. GLOBAL BIOPSY DEVICES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Biopsy Devices Market Dynamics – Factors Impact Analysis
3.6. Global Biopsy Devices Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL BIOPSY DEVICES MARKET, BY DEVICE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. DNA polymerase
5.1.1. Core biopsy devices
5.1.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Core biopsy needles
5.1.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.2. Core biopsy guns
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Needle-based biopsy devices
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Vacuum-assisted biopsy devices
5.4.1. Needles
5.4.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.1.3. Market Opportunity Analysis
5.4.2. Guns
5.4.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.2.3. Market Opportunity Analysis
5.5. Aspiration biopsy needles
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Gastrointestinal biopsy
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Lung
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Liver
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Breast biopsy
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Gynaecological
6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Kidney
6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY IMAGING TECHNOLOGY, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Ultrasound-guided biopsy
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Stereotactic guided biopsy
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. CT scan
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. MRI guided biopsy
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Clinics
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Diagnostic Centres
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User, and Region, 2017 – 2023
10. NORTH AMERICA BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Core biopsy devices
10.1.1.1. Core biopsy needles
10.1.1.2. Core biopsy guns
10.1.2. Needle-based biopsy devices
10.1.3. Vacuum-assisted biopsy devices
10.1.3.1. Needles
10.1.3.2. Guns
10.1.4. Aspiration biopsy needles
10.1.5. Others
10.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Gastrointestinal biopsy
10.2.2. Lung
10.2.3. Liver
10.2.4. Breast biopsy
10.2.5. Gynaecological
10.2.6. Kidney
10.2.7. Others
10.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Ultrasound-guided biopsy
10.3.2. Stereotactic guided biopsy
10.3.3. CT scan
10.3.4. MRI guided biopsy
10.3.5. Others
10.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Diagnostic Centres
10.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User, and Country, 2017 – 2023
10.7. North America Biopsy Devices Market Dynamics – Trends
11. EUROPE BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Core biopsy devices
11.1.1.1. Core biopsy needles
11.1.1.2. Core biopsy guns
11.1.2. Needle-based biopsy devices
11.1.3. Vacuum-assisted biopsy devices
11.1.3.1. Needles
11.1.3.2. Guns
11.1.4. Aspiration biopsy needles
11.1.5. Others
11.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Gastrointestinal biopsy
11.2.2. Lung
11.2.3. Liver
11.2.4. Breast biopsy
11.2.5. Gynaecological
11.2.6. Kidney
11.2.7. Others
11.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Ultrasound-guided biopsy
11.3.2. Stereotactic guided biopsy
11.3.3. CT scan
11.3.4. MRI guided biopsy
11.3.5. Others
11.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Diagnostic Centres
11.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User and Country, 2017 – 2023
11.7. Europe Biopsy Devices Market Dynamics – Trends
12. ASIA-PACIFIC BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Core biopsy devices
12.1.1.1. Core biopsy needles
12.1.1.2. Core biopsy guns
12.1.2. Needle-based biopsy devices
12.1.3. Vacuum-assisted biopsy devices
12.1.3.1. Needles
12.1.3.2. Guns
12.1.4. Aspiration biopsy needles
12.1.5. Others
12.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Gastrointestinal biopsy
12.2.2. Lung
12.2.3. Liver
12.2.4. Breast biopsy
12.2.5. Gynaecological
12.2.6. Kidney
12.2.7. Others
12.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Ultrasound-guided biopsy
12.3.2. Stereotactic guided biopsy
12.3.3. CT scan
12.3.4. MRI guided biopsy
12.3.5. Others
12.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Diagnostic Centres
12.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User and Country, 2017 – 2023
12.7. Europe Biopsy Devices Market Dynamics – Trends
13. LATIN AMERICA BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Core biopsy devices
13.1.1.1. Core biopsy needles
13.1.1.2. Core biopsy guns
13.1.2. Needle-based biopsy devices
13.1.3. Vacuum-assisted biopsy devices
13.1.3.1. Needles
13.1.3.2. Guns
13.1.4. Aspiration biopsy needles
13.1.5. Others
13.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Gastrointestinal biopsy
13.2.2. Lung
13.2.3. Liver
13.2.4. Breast biopsy
13.2.5. Gynaecological
13.2.6. Kidney
13.2.7. Others
13.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Ultrasound-guided biopsy
13.3.2. Stereotactic guided biopsy
13.3.3. CT scan
13.3.4. MRI guided biopsy
13.3.5. Others
13.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Diagnostic Centres
13.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User, and Country, 2017 – 2023
13.7. Latin America Biopsy Devices Market Dynamics – Trends
14. MIDDLE EAST AND AFRICA BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Core biopsy devices
14.1.1.1. Core biopsy needles
14.1.1.2. Core biopsy guns
14.1.2. Needle-based biopsy devices
14.1.3. Vacuum-assisted biopsy devices
14.1.3.1. Needles
14.1.3.2. Guns
14.1.4. Aspiration biopsy needles
14.1.5. Others
14.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Gastrointestinal biopsy
14.2.2. Lung
14.2.3. Liver
14.2.4. Breast biopsy
14.2.5. Gynaecological
14.2.6. Kidney
14.2.7. Others
14.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Ultrasound-guided biopsy
14.3.2. Stereotactic guided biopsy
14.3.3. CT scan
14.3.4. MRI guided biopsy
14.3.5. Others
14.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Diagnostic Centres
14.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User and Country, 2017 – 2023
14.7. MEA Biopsy Devices Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Becton, Dickinson and Company (U.S.)
15.2.2. Argon Medical Devices (U.S.)
15.2.3. Cardinal Health, Inc. (U.S.)
15.2.4. Boston Scientific Corporation (U.S.)
15.2.5. Medtronic plc (Ireland)
15.2.6. B. Braun Melsungen AG (Germany)
15.2.7. Olympus Corporation (Japan)
15.2.8. Hologic, Inc. (U.S.)
15.2.9. SmartTarget Ltd. (U.K.)
15.2.10. MDxHealth (Belgium)
15.2.11. Intact Medical Corporation (U.S.)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
2. GLOBAL BIOPSY DEVICES MARKET INTRODUCTION
2.1. Global Biopsy Devices Market – Taxonomy
2.2. Global Biopsy Devices Market –Definitions
2.2.1. Device
2.2.2. Application
2.2.3. Imaging Technology
2.2.4. End-User
3. GLOBAL BIOPSY DEVICES MARKET DYNAMICS
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Biopsy Devices Market Dynamics – Factors Impact Analysis
3.6. Global Biopsy Devices Market – Regulations
3.6.1. U.S.
3.6.2. Europe
4. GLOBAL BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023
4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis
5. GLOBAL BIOPSY DEVICES MARKET, BY DEVICE, 2012 - 2016 AND FORECAST, 2017 - 2023
5.1. DNA polymerase
5.1.1. Core biopsy devices
5.1.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.1.3. Market Opportunity Analysis
5.1.2. Core biopsy needles
5.1.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.2.3. Market Opportunity Analysis
5.2. Core biopsy guns
5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Needle-based biopsy devices
5.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Vacuum-assisted biopsy devices
5.4.1. Needles
5.4.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.1.3. Market Opportunity Analysis
5.4.2. Guns
5.4.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.2.3. Market Opportunity Analysis
5.5. Aspiration biopsy needles
5.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY APPLICATION, 2012 - 2016 AND FORECAST, 2017 - 2023
6.1. Gastrointestinal biopsy
6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Lung
6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Liver
6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Breast biopsy
6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Gynaecological
6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Kidney
6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Others
6.7.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
7. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY IMAGING TECHNOLOGY, 2012 - 2016 AND FORECAST, 2017 - 2023
7.1. Ultrasound-guided biopsy
7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Stereotactic guided biopsy
7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. CT scan
7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. MRI guided biopsy
7.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023
8.1. Hospitals
8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Clinics
8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Diagnostic Centres
8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. GLOBAL BIOPSY DEVICES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023
9.1. North America
9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User, and Region, 2017 – 2023
10. NORTH AMERICA BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
10.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Core biopsy devices
10.1.1.1. Core biopsy needles
10.1.1.2. Core biopsy guns
10.1.2. Needle-based biopsy devices
10.1.3. Vacuum-assisted biopsy devices
10.1.3.1. Needles
10.1.3.2. Guns
10.1.4. Aspiration biopsy needles
10.1.5. Others
10.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Gastrointestinal biopsy
10.2.2. Lung
10.2.3. Liver
10.2.4. Breast biopsy
10.2.5. Gynaecological
10.2.6. Kidney
10.2.7. Others
10.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Ultrasound-guided biopsy
10.3.2. Stereotactic guided biopsy
10.3.3. CT scan
10.3.4. MRI guided biopsy
10.3.5. Others
10.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Diagnostic Centres
10.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. U.S.
10.5.2. Canada
10.6. North America Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User, and Country, 2017 – 2023
10.7. North America Biopsy Devices Market Dynamics – Trends
11. EUROPE BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
11.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Core biopsy devices
11.1.1.1. Core biopsy needles
11.1.1.2. Core biopsy guns
11.1.2. Needle-based biopsy devices
11.1.3. Vacuum-assisted biopsy devices
11.1.3.1. Needles
11.1.3.2. Guns
11.1.4. Aspiration biopsy needles
11.1.5. Others
11.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Gastrointestinal biopsy
11.2.2. Lung
11.2.3. Liver
11.2.4. Breast biopsy
11.2.5. Gynaecological
11.2.6. Kidney
11.2.7. Others
11.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Ultrasound-guided biopsy
11.3.2. Stereotactic guided biopsy
11.3.3. CT scan
11.3.4. MRI guided biopsy
11.3.5. Others
11.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Diagnostic Centres
11.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Poland
11.5.8. Rest of Europe
11.6. Europe Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User and Country, 2017 – 2023
11.7. Europe Biopsy Devices Market Dynamics – Trends
12. ASIA-PACIFIC BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
12.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Core biopsy devices
12.1.1.1. Core biopsy needles
12.1.1.2. Core biopsy guns
12.1.2. Needle-based biopsy devices
12.1.3. Vacuum-assisted biopsy devices
12.1.3.1. Needles
12.1.3.2. Guns
12.1.4. Aspiration biopsy needles
12.1.5. Others
12.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Gastrointestinal biopsy
12.2.2. Lung
12.2.3. Liver
12.2.4. Breast biopsy
12.2.5. Gynaecological
12.2.6. Kidney
12.2.7. Others
12.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Ultrasound-guided biopsy
12.3.2. Stereotactic guided biopsy
12.3.3. CT scan
12.3.4. MRI guided biopsy
12.3.5. Others
12.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Diagnostic Centres
12.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User and Country, 2017 – 2023
12.7. Europe Biopsy Devices Market Dynamics – Trends
13. LATIN AMERICA BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
13.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Core biopsy devices
13.1.1.1. Core biopsy needles
13.1.1.2. Core biopsy guns
13.1.2. Needle-based biopsy devices
13.1.3. Vacuum-assisted biopsy devices
13.1.3.1. Needles
13.1.3.2. Guns
13.1.4. Aspiration biopsy needles
13.1.5. Others
13.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Gastrointestinal biopsy
13.2.2. Lung
13.2.3. Liver
13.2.4. Breast biopsy
13.2.5. Gynaecological
13.2.6. Kidney
13.2.7. Others
13.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Ultrasound-guided biopsy
13.3.2. Stereotactic guided biopsy
13.3.3. CT scan
13.3.4. MRI guided biopsy
13.3.5. Others
13.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Diagnostic Centres
13.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Argentina
13.5.4. Venezuela
13.5.5. Rest of Latin America
13.6. Latin America Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User, and Country, 2017 – 2023
13.7. Latin America Biopsy Devices Market Dynamics – Trends
14. MIDDLE EAST AND AFRICA BIOPSY DEVICES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023
14.1. Device Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Core biopsy devices
14.1.1.1. Core biopsy needles
14.1.1.2. Core biopsy guns
14.1.2. Needle-based biopsy devices
14.1.3. Vacuum-assisted biopsy devices
14.1.3.1. Needles
14.1.3.2. Guns
14.1.4. Aspiration biopsy needles
14.1.5. Others
14.2. Application Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.2.1. Gastrointestinal biopsy
14.2.2. Lung
14.2.3. Liver
14.2.4. Breast biopsy
14.2.5. Gynaecological
14.2.6. Kidney
14.2.7. Others
14.3. Imaging Technology Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Ultrasound-guided biopsy
14.3.2. Stereotactic guided biopsy
14.3.3. CT scan
14.3.4. MRI guided biopsy
14.3.5. Others
14.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Diagnostic Centres
14.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. Israel
14.5.3. South Africa
14.5.4. Rest of MEA
14.6. MEA Biopsy Devices Market - Opportunity Analysis Index, By Device, By Application, By Imaging Technology, By End-User and Country, 2017 – 2023
14.7. MEA Biopsy Devices Market Dynamics – Trends
15. COMPETITION LANDSCAPE
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Becton, Dickinson and Company (U.S.)
15.2.2. Argon Medical Devices (U.S.)
15.2.3. Cardinal Health, Inc. (U.S.)
15.2.4. Boston Scientific Corporation (U.S.)
15.2.5. Medtronic plc (Ireland)
15.2.6. B. Braun Melsungen AG (Germany)
15.2.7. Olympus Corporation (Japan)
15.2.8. Hologic, Inc. (U.S.)
15.2.9. SmartTarget Ltd. (U.K.)
15.2.10. MDxHealth (Belgium)
15.2.11. Intact Medical Corporation (U.S.)
16. RESEARCH METHODOLOGY
17. KEY ASSUMPTIONS AND ACRONYMS
